Susquehanna International Group’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,482,400
| Closed | -$126M | – | 11380 |
|
|
2019
Q4 | $126M | Sell |
1,482,400
-60,500
| -4% | -$4.03M | 0.04% | 403 |
|
|
2019
Q3 | $77.1M | Buy |
1,542,900
+538,300
| +54% | +$21.5M | 0.03% | 544 |
|
|
2019
Q2 | $36.6M | Buy |
1,004,600
+681,300
| +211% | +$22.2M | 0.01% | 868 |
|
|
2019
Q1 | $9.04M | Buy |
323,300
+82,300
| +34% | +$1.94M | ﹤0.01% | 1834 |
|
|
2018
Q4 | $4.61M | Sell |
241,000
-84,000
| -26% | -$1.95M | ﹤0.01% | 2372 |
|
|
2018
Q3 | $9.72M | Buy |
325,000
+252,200
| +346% | +$9.5M | ﹤0.01% | 1973 |
|
|
2018
Q2 | $2.67M | Sell |
72,800
-4,500
| -6% | -$146K | ﹤0.01% | 3563 |
|
|
2018
Q1 | $2.55M | Sell |
77,300
-63,600
| -45% | -$1.99M | ﹤0.01% | 3496 |
|
|
2017
Q4 | $3.85M | Sell |
140,900
-169,700
| -55% | -$5.23M | ﹤0.01% | 2869 |
|
|
2017
Q3 | $11.5M | Sell |
310,600
-36,500
| -11% | -$1.35M | ﹤0.01% | 1642 |
|
|
2017
Q2 | $13.2M | Sell |
347,100
-17,100
| -5% | -$762K | 0.01% | 1467 |
|
|
2017
Q1 | $17.8M | Sell |
364,200
-11,400
| -3% | -$520K | 0.01% | 1164 |
|
|
2016
Q4 | $12.7M | Sell |
375,600
-128,100
| -25% | -$4.54M | 0.01% | 1348 |
|
|
2016
Q3 | $19M | Buy |
503,700
+302,800
| +151% | +$11.4M | 0.01% | 1050 |
|
|
2016
Q2 | $6.76M | Buy |
200,900
+48,600
| +32% | +$1.71M | ﹤0.01% | 1841 |
|
|
2016
Q1 | $4.84M | Buy |
152,300
+41,000
| +37% | +$1.34M | ﹤0.01% | 2346 |
|
|
2015
Q4 | $4.16M | Buy |
111,300
+71,800
| +182% | +$2.71M | ﹤0.01% | 2783 |
|
|
2015
Q3 | $1.5M | Sell |
39,500
-271,700
| -87% | -$9.54M | ﹤0.01% | 4877 |
|
|
2015
Q2 | $8.9M | Sell |
311,200
-27,000
| -8% | -$752K | ﹤0.01% | 2144 |
|
|
2015
Q1 | $9.48M | Buy |
338,200
+301,900
| +832% | +$8.48M | ﹤0.01% | 1939 |
|
|
2014
Q4 | $1M | Sell |
36,300
-207,500
| -85% | -$5.14M | ﹤0.01% | 5882 |
|
|
2014
Q3 | $5.44M | Buy |
243,800
+150,800
| +162% | +$3.83M | ﹤0.01% | 2883 |
|
|
2014
Q2 | $2.7M | Sell |
93,000
-45,000
| -33% | -$1.2M | ﹤0.01% | 4083 |
|
|
2014
Q1 | $3.92M | Buy |
138,000
+92,900
| +206% | +$3.07M | ﹤0.01% | 3234 |
|
|
2013
Q4 | $1.74M | Sell |
45,100
-5,000
| -10% | -$179K | ﹤0.01% | 4527 |
|
|
2013
Q3 | $1.68M | Sell |
50,100
-131,400
| -72% | -$4.19M | ﹤0.01% | 4402 |
|
|
2013
Q2 | $5.58M | Buy |
+181,500
| New | +$6.07M | ﹤0.01% | 2478 |
|
Other funds holding MDCO
Susquehanna International Group's MDCO Position: Q1 2020 in Review
Susquehanna International Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,082,774 shares — an estimated $92M sold.
Susquehanna International Group first reported a position in MDCO in Q2 2013 and held it in 19 quarters. The position peaked at $92M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Susquehanna International Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Susquehanna International Group sold 1,082,774 Medicines Co shares in Q1 2020, an estimated $92M.
- Susquehanna International Group first reported a position in Medicines Co in Q2 2013 and held it in 19 quarters.
- Susquehanna International Group's Medicines Co position peaked at $92M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.